The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

The Efficacy of TACE Combined With Lenvatinib Plus Sintilimab in Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study

ObjectiveTo assess the efficacy and safety of transarterial Chemoembolization (TACE) combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma (HCC).Patients and MethodsThe data of patients with unresectable HCC administered a combination therapy with TACE and lenvatinib plus...

Full description

Bibliographic Details
Main Authors: Fei Cao, Yi Yang, Tongguo Si, Jun Luo, Hui Zeng, Zhewei Zhang, Duiping Feng, Yi Chen, Jiaping Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
targeted therapy
immunotherapy
comprehensive therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.783480/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.783480/full

Similar Items